Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
06/2010
06/16/2010CN101735880A Corrosion resistant ionic liquid lubricant and preparation method thereof
06/16/2010CN101735200A Quinazoline compound
06/16/2010CN101735162A Preparation method of rizatriptan benzoate midbody
06/16/2010CN101735161A Preparation method of rizatriptan benzoate intermediate
06/16/2010CN101735140A Chiral amino compound, method for synthesizing same and application of anti-flu medicament tamifiu intermediate thereof
06/16/2010CN101014338B 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2, 4-dione and analogues as inhibitors of macrophage elastase
06/15/2010US7737627 OLED/organic light emitters using a compound of 9,9-dimethylfluorenes anda ring such as carbazole for electrical stabity; glass transition temperature; crystal growth inhibiters; low voltage; current density; industrial scale; charge transfer/generating compounds; color dopes
06/15/2010US7737285 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction
06/15/2010US7737283 Urea substituted with a 5 member nitrogen-containing ring; biological conjugated drug used to modulate of the activation state of p38 kinase protein; antiinflammatory agents; rheumatoid arthritis, asthma, sepsis, toxic shock syndrome, adult respiratory distress syndrome, stroke, reperfusion injury
06/15/2010US7737275 simple and low cost chemical process of 2-chloro-5-[3,6-dihydro-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide
06/15/2010US7737172 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one, used for treating cellular proliferative disorders, nonproliferative degenerative disorders and viral diseases or infections
06/15/2010US7737171 Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS
06/15/2010US7737170 Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS
06/15/2010US7737166 such as 2-tert-Butyl-7-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-5-methyl-6-phenyl-1,3-benzoxazole-4-carbonitrile hydrochloride, a 1,6-beta-glucan synthetase inhibitor having potent growth inhibition, used treating a fungal infections; fungicides
06/15/2010US7737153 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
06/15/2010US7737152 6-carboaryl-oxy-pyrazin-2-yl-carboaryl-amines and compositions comprising said compounds
06/15/2010US7737149 Heterocyclic amides as anticancer agents
06/15/2010US7737148 Hydroxyiminopiperazines administered to animals as analgesics; inhibitors of vanilloid receptors
06/15/2010US7737143 such as 6-(1H-Benzimidazol-1-yl)-N-benzylpyrazin-2-amine, used as antidiabetic, anticarcinogenic and antiarthritic agents or for treating autoimmune diseases
06/15/2010US7737142 (Thio) carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists
06/10/2010WO2010065905A2 Compounds having antiparasitic or anti-infectious activity
06/10/2010WO2010065898A2 Egfr kinase knockdown via electrophilically enhanced inhibitors
06/10/2010WO2010065861A2 Inhibitors of bace 1 and methods for treating alzheimer's disease
06/10/2010WO2010065824A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
06/10/2010WO2010065802A2 Substituted pyrrolidine or imidazolidine melanocortin receptor-specific compounds
06/10/2010WO2010065746A2 Piperazine modulators of nk-1 receptors
06/10/2010WO2010065443A1 Synthesis and novel salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvinyl)pyrimidine
06/10/2010WO2010065432A1 Nitrooxy derivatives as angiotensin ii receptor antagonists
06/10/2010WO2010065110A2 Antimicrobials
06/10/2010WO2010064707A1 2h-chromene compound and derivative thereof
06/10/2010WO2010063610A1 Pyridazinone derivatives
06/10/2010US20100145048 Compounds for the treatment of inflammatory disorders
06/10/2010US20100145042 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
06/10/2010US20100145040 Benzazepine Derivatives For The Treatment of Neurological Disorders
06/10/2010US20100145036 Chemical linkers and cleavable substrates and conjugates thereof
06/10/2010US20100144821 Compounds and methods for treating protein folding disorders
06/10/2010US20100144810 Angiotensin ii receptor antagonists
06/10/2010US20100144798 Modulators of ATP-Binding Cassette Transporters
06/10/2010US20100144793 Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
06/10/2010US20100144747 1h-quinaz0line-2,4-diones
06/10/2010US20100144743 Compositions and methods for inhibition of tyrosine kinases
06/10/2010US20100144731 Novel Biccyclic Compounds As GATA Modulators
06/10/2010US20100144713 6-and 7-amino isoquinoline compounds and methods for making and using the same
06/10/2010US20100144712 Triazole derivatives having antifungal activity, method for the preparation thereof, and pharmaceutical composition comprising the same
06/10/2010US20100144710 Piperazine and Piperidine MGLUR5 Potentiators
06/10/2010US20100144706 Compounds
06/10/2010US20100144701 Modulators of CB1 Receptors
06/10/2010US20100144672 Pyrimidinyl pyrazoles as insecticides and parasiticide active agents
06/10/2010US20100143499 Dimeric iap inhibitors
06/10/2010US20100143387 Multimeric conjugate
06/10/2010US20100143299 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
06/10/2010US20100141130 Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative
06/10/2010US20100141122 Oled device with cyclobutene electron injection materials
06/10/2010CA2745787A1 Compounds having antiparasitic or anti-infectious activity
06/10/2010CA2745356A1 2h-chromene compound and derivative thereof
06/10/2010CA2745095A1 Nitrooxy derivatives as angiotensin ii receptor antagonists
06/10/2010CA2744708A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
06/10/2010CA2744489A1 Pyridazinone derivatives
06/10/2010CA2744152A1 Inhibitors of diacylglycerol acyltransferase
06/10/2010CA2742366A1 Synthesis and novel salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvinyl)pyrimidine
06/09/2010EP2194051A1 Process for preparing compounds useful as intermediates for the preparation of modulators of chemokine receptor activity
06/09/2010EP2194050A1 A new process for the preparation of irbesartan
06/09/2010EP2194046A1 Triazolone derivative
06/09/2010EP2193122A1 Imidazole derivatives
06/09/2010EP2193121A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
06/09/2010EP2193112A1 Electroluminescent device
06/09/2010EP2192901A2 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
06/09/2010EP2097374B1 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of v2 vasopressin receptors
06/09/2010EP1730115B1 5-aminoalkylpyrazole derivatives as pesticidal agents
06/09/2010EP1335907B1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
06/09/2010CN1910174B Indolylmaleimide derivatives
06/09/2010CN1910173B Indolylmaleimide derivatives as PKC inhibitors
06/09/2010CN1784391B Quinazolines useful as modulators of ion channels
06/09/2010CN1735607B 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer
06/09/2010CN1694874B Benzodiazepine derivatives and pharmaceutical compositions containing them
06/09/2010CN101730692A Pyridazinone derivatives useful as glucan synthase inhibitors
06/09/2010CN101730686A Piperazine compounds with herbicidal action
06/09/2010CN101730680A 4' substituted compounds having 5-ht6 receptor affinity
06/09/2010CN101723980A Triazole derivate used for treatment
06/09/2010CN101723937A imidazol-4-one and imidazole-4-thione compounds
06/09/2010CN101723936A Kinase suppressor and pharmaceutical application thereof
06/09/2010CN101723909A Triazolone compound as well as preparation method and application thereof
06/09/2010CN101723900A Cinnamide compound
06/09/2010CN101182308B Imidazole chiral ionic liquids containing double function groups as well as preparation method and uses thereof
06/09/2010CN101081847B Method for synthesizing N,N-dialkylamine phenyl-dipyrazole triazine structural light-sensitive molecule
06/09/2010CN101041637B Chiral amine protonic acid salt containing imidazole sulfur ether structure and preparation method and usage thereof
06/08/2010US7732605 inducing cyclization of an alpha -keto acid with an acid catalyst; N-2-oxo-propanoyl-L-phenylalanine amide; antitumor activity and selectivity
06/08/2010US7732601 salt formation in solvent; inoculation
06/08/2010US7732600 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
06/08/2010US7732456 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders
06/08/2010US7732449 preferential enzyme Inhibitors such as 4-(4-Acetyl-piperazin-1-yl)-2-(R)-cyclohexylmethyl-N-[1-(S)-methyl-2-(4-trifluoromethoxy-phenylamino)-ethyl]-4-oxo-butyramide, used for the treatment of inflammation, arthritis and atherosclerosis
06/08/2010US7732448 pesticides such as 4-(2-butynyloxy)-6-chloro-5-fluoropyrimidine, having an excellent ability to control pests
06/08/2010US7732445 Pyridazinyl compounds such as 11-(6-imino-3-phenylpyridazin-1(6H)-yl)-N-(2-(1-methylpyrrolidin-2-yl)ethyl)-undecanamide, use for the treatment of tissue barrier dysfunction, tumor metastasis and related disease states
06/08/2010US7731985 Preserving cosmetic, household or technical products, use in paper treatment liquors, printing thickeners, printing thickeners of starch or cellulose derivatives and paints
06/08/2010CA2479642C 4-anilino quinazoline derivatives as antiproliferative agents
06/08/2010CA2440553C 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
06/03/2010WO2010062686A2 Imidazol-4-one and imidazole-4-thione compounds
06/03/2010WO2010062507A1 Disubstituted phthalazine hedgehog pathway antagonists
06/03/2010WO2010062221A1 Substituted 2-(5-hydroxy-2-methyl-1n-indole-3-il) acetic acids and ethers thereof and the use of same to treat viral diseases
06/03/2010WO2010062171A2 Novel cc-1065 analogs and their conjugates
1 ... 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 ... 626